Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
LL-37: Side Effects & Safety
Known side effects, safety considerations, and adverse reaction data for LL-37.
Back to LL-37 overviewData source: Side effect data comes from clinical trials, preclinical research, and anecdotal reports. No FDA-approved labeling exists for this compound.
Reported Side Effects (4 items)
| # | Side Effect |
|---|---|
| 1 | Mild local irritation with topical application |
| 2 | Theoretical excessive immune stimulation |
| 3 | Theoretical autoimmunity risk from aberrant immune activation |
| 4 | Limited long-term safety data beyond 12 weeks |